PROJECT IMPACT HYPERLIPIDEMIA
DEAD

Serial Number

75586231

Owner

American Pharmaceutical Association (APhA) Foundation

Attorney

Joseph L. Morales

First Use Date

Mar 8, 1998

Filing Date

Nov 10, 1998

Add to watchlist:

No watchlists yet
View on USPTO

PROJECT IMPACT HYPERLIPIDEMIA Trademark

Serial Number: 75586231 • Registration: 2304152

PROJECT IMPACT HYPERLIPIDEMIA is a trademark filed by American Pharmaceutical Association (APhA) Foundation on November 10, 1998. The trademark is classified under Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

American Pharmaceutical Association (APhA) Foundation (2 trademarks)

2215 Constitution Avenue, N.W.
Washington, DC 200372985

Entity Type: 99

Trademark Details

Filing Date

November 10, 1998

Registration Date

December 28, 1999

First Use Anywhere

March 8, 1998

First Use in Commerce

March 8, 1998

Published for Opposition

October 5, 1999

Cancellation Date

July 31, 2010

Goods & Services

MEDICAL RESEARCH AND TESTING, AND PROVIDING HEALTH INFORMATION IN THE FIELD OF PHARMACEUTICAL SCIENCE

Filing History

CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Jul 31, 2010 CAEX
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 31, 2009 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 31, 2009 REAP
CASE FILE IN TICRS
May 31, 2006 CFIT
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Jan 31, 2006 C15A
ASSIGNED TO PARALEGAL
Jan 31, 2006 PLGL
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Dec 20, 2005 815F
PAPER RECEIVED
Dec 20, 2005 MAIL
REGISTERED-PRINCIPAL REGISTER
Dec 28, 1999 R.PR
PUBLISHED FOR OPPOSITION
Oct 5, 1999 PUBO
NOTICE OF PUBLICATION
Sep 3, 1999 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Jun 21, 1999 CNSA
EXAMINER'S AMENDMENT MAILED
Jun 9, 1999 CNEA
ASSIGNED TO EXAMINER
May 11, 1999 DOCK
ASSIGNED TO EXAMINER
May 11, 1999 DOCK